Lupus-prone mice fail to raise antigen-specific T cell responses to intracellular infection

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Lieberman, Linda A ^a   Tsokos, George C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; PARASITE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELLULAR IMMUNITY; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DENDRITIC CELL; FEMALE; INFECTION SENSITIVITY; MOUSE; NONHUMAN; PARASITE LOAD; PARASITOSIS; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TOXOPLASMOSIS; ANIMAL; DISEASE PREDISPOSITION; IMMUNOLOGY; INTRACELLULAR SPACE; PARASITOLOGY; PHYSIOLOGY; TOXOPLASMA;

MUS;

ANIMALS; ANTIGENS, PROTOZOAN; DISEASE SUSCEPTIBILITY; FEMALE; INTRACELLULAR SPACE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; T-LYMPHOCYTES; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

EID: 84909997994     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111382     Document Type: Article

References (31)

1. Tsokos GC (2011) Systemic lupus erythematosus. NEJM 365: 2110-2121.
2. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, et al. (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82: 299-308.
3. Goldblatt F, Chambers S, Rahman A, Isenberg DA (2009) Serious infections in British patients with systemic lupus erythematosus: hospitalisations and mortality. Lupus 18: 682-689.
4. Mok CC, Lau CS (2003) Pathogenesis of systemic lupus erythematosus. J Clin Pathol 56: 481-490.
5. Lieberman LA, Tsokos GC (2010) The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity. J Biomed Biotechnol 2010: 740619.
6. Iliopoulos AG, Tsokos GC (1996) Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin Arthritis Rheum 25: 318-336.
7. Maddur MS, Vani J, Lacroix-Desmazes S, Kaveri S, Bayry J (2010) Autoimmunity as a predisposition for infectious diseases. PLoS Pathog 6: e1001077.
8. Doria A, Canova M, Tonon M, Zen M, Rampudda E, et al. (2008) Infections as triggers and complications of systemic lupus erythematosus. Autoimmun Rev 8: 24-28.
9. Hunter CA, Sibley LD (2012) Modulation of innate immunity by Toxoplasma gondii virulence effectors. Nat Rev Microbiol 10: 766-778.
10. Dupont CD, Christian DA, Hunter CA (2012) Immune response and immunopathology during toxoplasmosis. Semin Immunopathol 34: 793-813.
11. Wilcox MH, Powell RJ, Pugh SF, Balfour AH (1990) Toxoplasmosis and systemic lupus erythematosus. Ann Rheum Dis 49: 254-257.
12. Zamir D, Amar M, Groisman G, Weiner P (1999) Toxoplasma infection in systemic lupus erythematosus mimicking lupus cerebritis. Mayo Clin Proc 74: 575-578.
13. Sharma SD, Mullenax J, Araujo FG, Erlich HA, Remington JS (1983) Western Blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies. J Immunol 131: 977-983.
14. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317.
15. Subramanian S, Tus K, Li QZ, Wang A, Tian XH, et al. (2006) A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. PNAS 103: 9970-9975.
16. Chen M, Aosai F, Norose K, Mun HS, Ishikura H, et al. (2004) Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice. Int Immunol 16: 937-946.
17. Lieberman LA, Cardillo F, Owyang AM, Rennick DM, Cua DJ, et al. (2004) IL- 23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12. J Immunol 173: 1887-1893.
18. Harigai M, Kawamoto M, Hara M, Kubota T, Kamatani N, et al. (2008) Excessive production of IFN-gamma in patients with systemic lupus erythematosus and its contribution to induction of B lymphocyte stimulator/B cellactivating factor/TNF ligand superfamily-13B. J Immunol 181: 2211-2219.
19. Nickell SP, Hoff R, Boyer MH (1985) Susceptibility to acute Trypanosoma cruzi infection in autoimmune strains of mice. Parasite Immunol 7: 377-386.
20. Hunter CA, Subauste CS, Van Cleave VH, Remington JS (1994) Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect Immun 62: 2818-2824.
21. Gazzinelli R, Xu Y, Hieny S, Cheever A, Sher A (1992) Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J Immunol 149: 175-180.
22. Viallard JF, Pellegrin JL, Ranchin V, Schaeverbeke T, Dehais J, et al. (1999) Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 115: 189-195.
23. Tucci M, Lombardi L, Richards HB, Dammacco F, Silvestris F (2008) Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis. Clin Exp Immunol 154: 247-254.
24. Nakashima H, Inoue H, Akahoshi M, Tanaka Y, Yamaoka K, et al. (1999) The combination of polymorphisms within interferon-gamma receptor 1 and receptor 2 associated with the risk of systemic lupus erythematosus. FEBS Lett 453: 187-190.
25. Tanaka Y, Nakashima H, Hisano C, Kohsaka T, Nemoto Y, et al. (1999) Association of the interferon-gamma receptor variant (Val14Met) with systemic lupus erythematosus. Immunogenetics 49: 266-271.
26. Yao X, Chen ZQ, Gong JQ, Chen M, Li AS, et al. (2007) The interferongamma receptor gene polymorphisms (Val14Met and Gln64Arg) are not associated with systemic lupus erythematosus in Chinese patients. Arch Dermatol Res 299: 367-371.
27. Theofilopoulos AN, Koundouris S, Kono DH, Lawson BR (2001) The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity. Arthritis Res 3: 136-141.
28. Moulton VR, Tsokos GC (2011) Abnormalities of T cell signaling in systemic lupus erythematosus. Arthritis Res Ther 13: 207.
29. Francisco LM, Sage PT, Sharpe AH (2010) The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 236: 219-242.
30. Bhadra R, Gigley JP, Weiss LM, Khan IA (2011) Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade. Proc Natl Acad Sci U S A 108: 9196-9201.
31. Rowe JH, Johanns TM, Ertelt JM, Way SS (2008) PDL-1 blockade impedes T cell expansion and protective immunity primed by attenuated Listeria monocytogenes. J Immunol 180: 7553-7557.